AFT Pharmaceuticals

Started by Hectorplains, Jan 09, 2023, 09:22 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

lorraina

My shares seem to go in cycles.
Just when I have my doubts they come right.
Then when I start to think I am clever, the market turns round and kicks me in the back side,and says you are still a dummy..lol.



Basil

Average price of more recognised analysts on Market screener is $4.65.


lorraina

I see research from Forbar and Craigs.Neither have covered AFT.
The latest research as far as I know is Pitt Street's.
I have already posted that Pitt Street's research is often suspect,although they got it 100% right on ATP.Atlas Pearls.
What I like about AFT.
It is in the medical sector.[Good margins]
Has a big market presence in both Australia and NZ.
Future growth is world wide.
Means I can buy a NZ listed company with growing overseas earnings.
Its products are excellent,
Its products are well presented in chemist shops.Very good bold displays.
Sales momentum is building rapidly.
Leader driven.
The business is profitable and pays a dividend.
The business is very scalable.
Current PE ratio of 30.30 may be modest for a company with such potential.

Minimoke

Quote from: lorraina on Jul 27, 2026, 09:59 AMI see research from Forbar and Craigs.Neither have covered AFT.
The latest research as far as I know is Pitt Street's.
I have already posted that Pitt Street's research is often suspect,although they got it 100% right on ATP.Atlas Pearls.
What I like about AFT.
It is in the medical sector.[Good margins]
Has a big market presence in both Australia and NZ.
Future growth is world wide.
Means I can buy a NZ listed company with growing overseas earnings.
Its products are excellent,
Its products are well presented in chemist shops.Very good bold displays.
Sales momentum is building rapidly.
Leader driven.
The business is profitable and pays a dividend.
The business is very scalable.
Current PE ratio of 30.30 may be modest for a company with such potential.
The biggest problem I have is Hartly Atkinson owns 69%

Left Field

Crilkey..... lots of updates lately

https://www.nzx.com/announcements/476766

AFT R&D Portfolio Offers Multi-$bn Market Potential


"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

lorraina

#80
Quote from: Basil on Jul 26, 2026, 11:36 AMAverage price of more recognised analysts on Market screener is $4.65.


Well two days later we are nearly there.
Share price currently $4.48...lol

lorraina

#81
Forbar research today target price $5.05.
Outperform..
We believe AFT's current
valuation attributes minimal value to either its R&D pipeline or its fast-growing international businesses.
...........................26a.................27e....................28e..................29e.
eps......................13.4...............19.2..................25.2..................33.3
eps growth.................43.28%..............32.25%..............32.14%............av.32.22%
PEG ratio.Current PE 31 divided by 32.22 gives PEG of .96 ie under 1 which is positive.
Fun is if you divide the current PE by the one year growth..31 by 43.28 then PEG comes down to .71.Incredible.?

winner (n)

Incredible numbers eh percy

Go team Hartley ....at $5 Forbar will be saying $6

lorraina

Yes incredible numbers.
And it is also incredible Hartley is now doing what he says he will do.